Cargando…

Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification

Serotonergic psychedelics, substances exerting their effects primarily through the serotonin 2A receptor (5HT2AR), continue to comprise a substantial portion of reported new psychoactive substances (NPS). In this paper five quantitative structure–activity relationship (QSAR) models for predicting th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Floresta, Giuseppe, Abbate, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697832/ https://www.ncbi.nlm.nih.gov/pubmed/35424006 http://dx.doi.org/10.1039/d1ra01335a

Ejemplares similares

FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets
por: Floresta, Giuseppe, et al.
Publicado: (2018)

Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis †
por: Floresta, Giuseppe, et al.
Publicado: (2018)

Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling
por: Failla, Mariacristina, et al.
Publicado: (2023)

Comprehensive Protocol for the Identification and Characterization of New Psychoactive Substances in the Service of Law Enforcement Agencies
por: Bulska, Ewa, et al.
Publicado: (2020)

Molecular Networking: A Useful Tool for the Identification of New Psychoactive Substances in Seizures by LC–HRMS
por: Vincenti, Flaminia, et al.
Publicado: (2020)

Integration of machine learning in 3D-QSAR CoMSIA models for the identification of lipid antioxidant peptides
por: Nha Tran, Thi Thanh, et al.
Publicado: (2023)

Simultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewater
por: Bade, Richard, et al.
Publicado: (2019)

Detection of newly emerging psychoactive substances using Raman spectroscopy and chemometrics
por: Calvo-Castro, Jesus, et al.
Publicado: (2018)

Sigma-2 receptor ligands QSAR model dataset
por: Rescifina, Antonio, et al.
Publicado: (2017)

iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer
por: Cilibrizzi, Agostino, et al.
Publicado: (2018)

Development and validation of the UPLC-MS method for simultaneous determination of six new psychoactive substances
por: Tan, Zhouhong, et al.
Publicado: (2022)

Predicting the emission wavelength of organic molecules using a combinatorial QSAR and machine learning approach
por: Ye, Zong-Rong, et al.
Publicado: (2020)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography
por: Floresta, Giuseppe, et al.
Publicado: (2022)

Activity evaluation of some psychoactive drugs with the application of QSAR/QSPR modeling methods
por: Kawczak, Piotr, et al.
Publicado: (2018)

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering
por: Muhamadali, Howbeer, et al.
Publicado: (2019)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Development of QSAR machine learning-based models to forecast the effect of substances on malignant melanoma cells
por: Ancuceanu, Robert, et al.
Publicado: (2019)

Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes
por: Floresta, Giuseppe, et al.
Publicado: (2022)

Rapid Identification of Novel Psychoactive and Other Controlled Substances Using Low-Field (1)H NMR Spectroscopy
por: Antonides, Lysbeth H., et al.
Publicado: (2019)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules
por: Floresta, Giuseppe, et al.
Publicado: (2019)

Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
por: Bertol, Elisabetta, et al.
Publicado: (2017)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Validation of a Bioanalytical Method for the Determination of Synthetic and Natural Cannabinoids (New Psychoactive Substances) in Oral Fluid Samples by Means of HPLC-MS/MS
por: Calò, Luca, et al.
Publicado: (2020)

Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances
por: Guillou, Claude, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dpn0rn3dud3vb98t0dd2vd0c22